Targeted hyperthermia using metal nanoparticles
- PMID: 19909777
- PMCID: PMC2827640
- DOI: 10.1016/j.addr.2009.11.006
Targeted hyperthermia using metal nanoparticles
Abstract
Despite the use of hyperthermia to treat cancer for thousands of years, the challenge of only heating malignant cells remains daunting. In pre-clinical and early clinical trials, metal nanoparticles induce hyperthermic cytotoxicity when exposed to near-infrared radiation or radiofrequency fields. We discuss the emerging roles of nanoparticles, especially gold, in the hyperthermic treatment of cancer. In addition, we discuss the similarities of radiofrequency ablation and nanoparticle mediated cytotoxicity.
Copyright 2009 Elsevier B.V. All rights reserved.
Figures
References
-
- Link S, El-Sayed MA. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu Rev Phys Chem. 2003;54:331–66. - PubMed
-
- Hartman KB, Wilson LJ, Rosenblum MG. Detecting and treating cancer with nanotechnology. Mol Diagn Ther. 2008;12:1–14. - PubMed
-
- Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomed. 2008;3:137–40. - PubMed
-
- Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14:1310–6. - PubMed
-
- Hartman KB, Wilson LJ. Carbon nanostructures as a new high-performance platform for MR molecular imaging. Adv Exp Med Biol. 2007;620:74–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
